These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 3540012)

  • 41. Changes in c-myc and c-fos expression in a human tumor cell line following exposure to bifunctional alkylating agents.
    Futscher BW; Erickson LC
    Cancer Res; 1990 Jan; 50(1):62-6. PubMed ID: 2104539
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Elongation and maturation of c-myc RNA is inhibited by differentiation inducing agents in HL60 cells.
    Eick D
    Nucleic Acids Res; 1990 Mar; 18(5):1199-205. PubMed ID: 2320415
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Alternative modes of c-myc regulation in growth factor-stimulated and differentiating cells.
    Nepveu A; Levine RA; Campisi J; Greenberg ME; Ziff EB; Marcu KB
    Oncogene; 1987; 1(3):243-50. PubMed ID: 2455262
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Sequential expression of proto-oncogenes during a mouse erythroleukemia cell differentiation.
    Todokoro K; Ikawa Y
    Biochem Biophys Res Commun; 1986 Mar; 135(3):1112-8. PubMed ID: 3457564
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of tiazofurin on protooncogene expression during HL-60 cell differentiation.
    Kharbanda SM; Sherman ML; Spriggs DR; Kufe DW
    Cancer Res; 1988 Nov; 48(21):5965-8. PubMed ID: 2901907
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Synergistic effect of retinoic acid and calcium ionophore A23187 on differentiation, c-myc expression, and membrane tyrosine kinase activity in human promyelocytic leukemia cell line HL-60.
    Chapekar MS; Hartman KD; Knode MC; Glazer RI
    Mol Pharmacol; 1987 Feb; 31(2):140-5. PubMed ID: 3100942
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Differentiation of F9 cells is independent of c-myc expression.
    Nishikura K; Kim U; Murray JM
    Oncogene; 1990 Jul; 5(7):981-8. PubMed ID: 1695728
    [TBL] [Abstract][Full Text] [Related]  

  • 48. An oligomer complementary to c-myc mRNA inhibits proliferation of HL-60 promyelocytic cells and induces differentiation.
    Holt JT; Redner RL; Nienhuis AW
    Mol Cell Biol; 1988 Feb; 8(2):963-73. PubMed ID: 3280975
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Exogenous c-myc gene overexpression interferes with early events in F9 cell differentiation.
    Onclercq R; Babinet C; Cremisi C
    Oncogene Res; 1989; 4(4):293-302. PubMed ID: 2671866
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Modulation of c-myc, c-myb, c-fos, c-sis and c-fms proto-oncogene expression and of CSF-1 transcripts and protein by phorbol diester in human malignant histiocytosis DEL cell line with 5q 35 break point.
    Gogusev J; Barbey S; Nezelof C
    Anticancer Res; 1993; 13(4):1043-7. PubMed ID: 8352523
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Studies of c-myb gene regulation in MRL-lpr/lpr mice. Identification of a 5' c-myb nuclear protein binding site and high levels of binding factors in nuclear extracts of lpr/lpr lymph node cells.
    Mountz JD; Steinberg AD
    J Immunol; 1989 Jan; 142(1):328-35. PubMed ID: 2642505
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Phorbol ester-mediated inhibition of growth and regulation of proto-oncogene expression in the human T cell leukemia line JURKAT.
    Makover D; Cuddy M; Yum S; Bradley K; Alpers J; Sukhatme V; Reed JC
    Oncogene; 1991 Mar; 6(3):455-60. PubMed ID: 2011401
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Analysis of polyadenylation site usage of the c-myc oncogene.
    Laird-Offringa IA; Elfferich P; Knaken HJ; de Ruiter J; van der Eb AJ
    Nucleic Acids Res; 1989 Aug; 17(16):6499-514. PubMed ID: 2674898
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Expression of c-myc changes during differentiation of mouse erythroleukaemia cells.
    Lachman HM; Skoultchi AI
    Nature; 1984 Aug 16-22; 310(5978):592-4. PubMed ID: 6462247
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The expression of the myc proto-oncogene in a dimethylsulfoxide resistant HL-60 cell line.
    Grosso LE; Pitot HC
    Cancer Lett; 1984 Feb; 22(1):55-63. PubMed ID: 6583000
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evidence that the familial adenomatous polyposis gene is involved in a subset of colon cancers with a complementable defect in c-myc regulation.
    Erisman MD; Scott JK; Astrin SM
    Proc Natl Acad Sci U S A; 1989 Jun; 86(11):4264-8. PubMed ID: 2542967
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Novel promoter upstream of the human c-myc gene and regulation of c-myc expression in B-cell lymphomas.
    Bentley DL; Groudine M
    Mol Cell Biol; 1986 Oct; 6(10):3481-9. PubMed ID: 3540591
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Early regulation of c-myc mRNA by 1,25-dihydroxyvitamin D3 in human myelomonocytic U937 cells.
    Karmali R; Bhalla AK; Farrow SM; Williams MM; Lal S; Lydyard PM; O'Riordan JL
    J Mol Endocrinol; 1989 Jul; 3(1):43-8. PubMed ID: 2663020
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Transcriptional regulation of myeloperoxidase gene expression in myeloid leukemia HL-60 cells during differentiation into granulocytes and macrophages.
    Sagoh T; Yamada M
    Arch Biochem Biophys; 1988 May; 262(2):599-604. PubMed ID: 2835011
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of sodium butyrate on the rearranged c-myc expression in mouse plasmacytoma cells.
    Kondoh N; Oikawa T; Satoh C; Kuzumaki N
    Exp Cell Res; 1991 Sep; 196(1):146-9. PubMed ID: 1879469
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.